Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline and amorphous forms of a β-arrestin effector

Crystalline and amorphous forms of a β-arrestin effector

US Patent 9518086 · Granted Dec 13, 2016

Estimated economic value: $4,524,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfoxide and sulfone glucokinase activators and methods of use thereof2025
Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one deriva2020
Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one deriva2019
Micronized colistimethane sodium pharmaceutical compositions2019
Method for refracturing a wellbore and low molecular weight compositions for use2019
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphoox2017
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphoox2017
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphoox2017
Synthesis of beta-arrestin effectors2017
Synthesis of beta-arrestin effectors2017
Synthesis of beta-arrestin effectors2017
Synthesis of beta-arrestin effectors2017